Analysed AUTONOMIX MEDICAL INC (AMIX:NASDAQ) News Sources
Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine
04-06-2026
yahoo.com
Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change
22-06-2026
yahoo.com
Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant
13-07-2026
yahoo.com
Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
14-07-2026
yahoo.com
Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform
15-07-2026
yahoo.com
Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy
04-08-2026
yahoo.com
Autonomix Medical Receives U.S. Patent for Precision Neuromodulation Platform Expansion
04-08-2026
advfn.com
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
12-08-2026
yahoo.com
What is the current price of AUTONOMIX MEDICAL INC (AMIX:NASDAQ)?
The current price of AUTONOMIX MEDICAL INC (AMIX:NASDAQ) is $5.37.
AUTONOMIX MEDICAL INC (AMIX:NASDAQ) absolute price change since previous trading day?
The absolute price change of AUTONOMIX MEDICAL INC (AMIX:NASDAQ) since the previous trading day is $0.1.
AUTONOMIX MEDICAL INC (AMIX:NASDAQ) percentage price change since previous trading day?
The percentage price change of AUTONOMIX MEDICAL INC (AMIX:NASDAQ) since the previous trading day is 1.8975%.
What is the most recent average sentiment score for AUTONOMIX MEDICAL INC (AMIX:NASDAQ)?
The most recent average sentiment score for AUTONOMIX MEDICAL INC (AMIX:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for AUTONOMIX MEDICAL INC (AMIX:NASDAQ)?
The most recent sentiment for AUTONOMIX MEDICAL INC (AMIX:NASDAQ) is .
SEC-8K** Filing Available For AUTONOMIX MEDICAL INC (AMIX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.